Artificial intelligence in tuberculosis: a new ally in disease control

The challenges to effective tuberculosis (TB) disease control are considerable, and the current global targets for reductions in disease burden seem unattainable. The combination of complex pathophysiology and technical limitations results in difficulties in achieving consistent, reliable diagnoses, and long treatment regimens imply serious physiological and socioeconomic consequences for patients. Artificial intelligence (AI) applications in healthcare have significantly improved patient care regarding diagnostics, treatment and basic research. However, their success relies on infrastructures prioritising comprehensive data generation and collaborative research environments to foster stakeholder engagement. This viewpoint article briefly outlines the current and potential applications of advanced AI models in global TB control and the considerations and implications of adopting these tools within the public health community.

Authors

Institutions

Publication Details

Journal
Breathe
Published
2024-10-01
DOI
https://doi.org/10.1183/20734735.0056-2024
Citations
12
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
4.67
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Artificial intelligence in tuberculosis: a new ally in disease control

Raquel Duarte, Christoph Lange, Fabian Joachim Theis, Traian Constantin Panciu et al.
12 citations
Breathe
Tuberculosis Research and Epidemiology
4.67
article

Artificial intelligence in tuberculosis: a new ally in disease control

Raquel Duarte, Christoph Lange, Fabian Joachim Theis, Traian Constantin Panciu, M. McClean
article en
12 citations

Abstract

The challenges to effective tuberculosis (TB) disease control are considerable, and the current global targets for reductions in disease burden seem unattainable. The combination of complex pathophysiology and technical limitations results in difficulties in achieving consistent, reliable diagnoses, and long treatment regimens imply serious physiological and socioeconomic consequences for patients. Artificial intelligence (AI) applications in healthcare have significantly improved patient care regarding diagnostics, treatment and basic research. However, their success relies on infrastructures prioritising comprehensive data generation and collaborative research environments to foster stakeholder engagement. This viewpoint article briefly outlines the current and potential applications of advanced AI models in global TB control and the considerations and implications of adopting these tools within the public health community.

BreatheVol. 20(3)
Universidade do Porto (PT), Helmholtz Zentrum München (DE), LMU Klinikum (DE), German Center for Infection Research (DE), Institutul de Pneumoftiziologie "Marius Nasta" (RO), Research Center Borstel - Leibniz Lung Center (DE), Instituto de Saúde (BR), Texas Children's Hospital (US), i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto (PT), Technical University of Munich (DE), Ludwig-Maximilians-Universität München (DE), University of Lübeck (DE)
Industry, innovation and infrastructure
Openalex Percentile: Top 4%
Tuberculosis Research and Epidemiology
4.67
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Artificial intelligence in tuberculosis: a new ally in disease control — Raquel Duarte, Christoph Lange, et al. · Breathe (2024) | TGRS Research Map | TGRS